{
  "doc_id": "4",
  "paragraphs": [
    {
      "paragraph_id": "0",
      "paragraph": "2型糖尿病合并慢性肾脏病患者口服降糖药用药原则中国专家共识",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2型糖尿病合并慢性肾脏病患者口服降糖药用药原则中国专家共识",
          "start_idx": 0,
          "end_idx": 29,
          "entities": [
            {
              "entity_id": "T0",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 5
            },
            {
              "entity_id": "T1",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 0,
              "end_idx": 2
            },
            {
              "entity_id": "T2",
              "entity": "慢性肾脏病",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 12
            },
            {
              "entity_id": "T3",
              "entity": "肾脏",
              "entity_type": "Anatomy",
              "start_idx": 9,
              "end_idx": 11
            },
            {
              "entity_id": "T4",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 14,
              "end_idx": 16
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R0",
              "head_entity_id": "T1",
              "tail_entity_id": "T0"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R1",
              "head_entity_id": "T3",
              "tail_entity_id": "T2"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "1",
      "paragraph": "慢性肾脏病(CKD)是严重威胁人类健康的常见慢性病，病因多种多样，由糖尿病所引发的肾脏病称为糖尿病肾脏病(DKD)。T2DM常合并CKD，高血糖是CKD发展的主要原因之一，降糖治疗至关重要。口服降糖药作为临床最常用的降糖手段，对于血糖控制具有重要意义。近年来，T2DM合并CKD患者中口服降糖药治疗证据不断丰富，国外糖尿病及肾脏病权威指南规范了口服降糖药的应用，但我国尚缺乏T2DM合并CKD用药指南或共识。为规范临床用药，中国医师协会内分泌代谢科医师分会组织国内的内分泌科和肾内科领域专家共同制定了本共识。对于口服降糖药在T2DM合并CKD患者的应用，参考药品说明书、近期国际指南及经典专著，如“The Kidney”，若缺乏用药经验，则依据从严原则，以保护医患利益。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "慢性肾脏病(CKD)是严重威胁人类健康的常见慢性病，病因多种多样，由糖尿病所引发的肾脏病称为糖尿病肾脏病(DKD)。T2DM常合并CKD，高血糖是CKD发展的主要原因之一，降糖治疗至关重要。",
          "start_idx": 0,
          "end_idx": 95,
          "entities": [
            {
              "entity_id": "T5",
              "entity": "慢性肾脏病(CKD)",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 10
            },
            {
              "entity_id": "T6",
              "entity": "肾脏",
              "entity_type": "Anatomy",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T7",
              "entity": "糖尿病",
              "entity_type": "Reason",
              "start_idx": 34,
              "end_idx": 37
            },
            {
              "entity_id": "T8",
              "entity": "糖尿病肾脏病(DKD)",
              "entity_type": "Disease",
              "start_idx": 46,
              "end_idx": 57
            },
            {
              "entity_id": "T9",
              "entity": "肾脏病",
              "entity_type": "Disease",
              "start_idx": 41,
              "end_idx": 44
            },
            {
              "entity_id": "T10",
              "entity": "肾脏",
              "entity_type": "Anatomy",
              "start_idx": 41,
              "end_idx": 43
            },
            {
              "entity_id": "T11",
              "entity": "肾脏",
              "entity_type": "Anatomy",
              "start_idx": 49,
              "end_idx": 51
            },
            {
              "entity_id": "T12",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 58,
              "end_idx": 62
            },
            {
              "entity_id": "T13",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 58,
              "end_idx": 60
            },
            {
              "entity_id": "T14",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 65,
              "end_idx": 68
            },
            {
              "entity_id": "T15",
              "entity": "高血糖",
              "entity_type": "Reason",
              "start_idx": 69,
              "end_idx": 72
            },
            {
              "entity_id": "T16",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 73,
              "end_idx": 76
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R2",
              "head_entity_id": "T6",
              "tail_entity_id": "T5"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R3",
              "head_entity_id": "T7",
              "tail_entity_id": "T9"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R4",
              "head_entity_id": "T11",
              "tail_entity_id": "T8"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R5",
              "head_entity_id": "T10",
              "tail_entity_id": "T9"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R6",
              "head_entity_id": "T13",
              "tail_entity_id": "T12"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R7",
              "head_entity_id": "T15",
              "tail_entity_id": "T16"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "口服降糖药作为临床最常用的降糖手段，对于血糖控制具有重要意义。",
          "start_idx": 95,
          "end_idx": 126,
          "entities": [
            {
              "entity_id": "T17",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 0,
              "end_idx": 2
            },
            {
              "entity_id": "T18",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 20,
              "end_idx": 22
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "近年来，T2DM合并CKD患者中口服降糖药治疗证据不断丰富，国外糖尿病及肾脏病权威指南规范了口服降糖药的应用，但我国尚缺乏T2DM合并CKD用药指南或共识。",
          "start_idx": 126,
          "end_idx": 204,
          "entities": [
            {
              "entity_id": "T19",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 8
            },
            {
              "entity_id": "T20",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 4,
              "end_idx": 6
            },
            {
              "entity_id": "T21",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 13
            },
            {
              "entity_id": "T22",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 16,
              "end_idx": 18
            },
            {
              "entity_id": "T23",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 32,
              "end_idx": 35
            },
            {
              "entity_id": "T24",
              "entity": "肾脏病",
              "entity_type": "Disease",
              "start_idx": 36,
              "end_idx": 39
            },
            {
              "entity_id": "T25",
              "entity": "肾脏",
              "entity_type": "Anatomy",
              "start_idx": 36,
              "end_idx": 38
            },
            {
              "entity_id": "T26",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 46,
              "end_idx": 48
            },
            {
              "entity_id": "T27",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 61,
              "end_idx": 65
            },
            {
              "entity_id": "T28",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 61,
              "end_idx": 63
            },
            {
              "entity_id": "T29",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 67,
              "end_idx": 70
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R8",
              "head_entity_id": "T20",
              "tail_entity_id": "T19"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R9",
              "head_entity_id": "T25",
              "tail_entity_id": "T24"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R10",
              "head_entity_id": "T28",
              "tail_entity_id": "T27"
            }
          ]
        },
        {
          "sentence_id": "3",
          "sentence": "为规范临床用药，中国医师协会内分泌代谢科医师分会组织国内的内分泌科和肾内科领域专家共同制定了本共识。",
          "start_idx": 204,
          "end_idx": 254,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "4",
          "sentence": "对于口服降糖药在T2DM合并CKD患者的应用，参考药品说明书、近期国际指南及经典专著，如“The Kidney”，若缺乏用药经验，则依据从严原则，以保护医患利益。",
          "start_idx": 254,
          "end_idx": 335,
          "entities": [
            {
              "entity_id": "T30",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T31",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 12
            },
            {
              "entity_id": "T32",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 8,
              "end_idx": 10
            },
            {
              "entity_id": "T33",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 14,
              "end_idx": 17
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R11",
              "head_entity_id": "T32",
              "tail_entity_id": "T31"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "2",
      "paragraph": "一、T2DM合并CKD的流行病学",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "一、T2DM合并CKD的流行病学",
          "start_idx": 0,
          "end_idx": 16,
          "entities": [
            {
              "entity_id": "T34",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6
            },
            {
              "entity_id": "T35",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T36",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R12",
              "head_entity_id": "T35",
              "tail_entity_id": "T34"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "3",
      "paragraph": "我国糖尿病患病率逐年升高，目前糖尿病患者约9240万，其中T2DM占90%以上。糖尿病与CKD关系密切。糖尿病患者CKD发生风险较非糖尿病者增加2.6倍。近年，各地CKD流行病学调查成年人CKD的患病率存在一定差异，为9%~14%。近期全国CKD流行病学调查显示，我国成年人中CKD患病率为10.8%，据此估算18岁以上人群CKD患者人数约1.195亿。在发达国家，糖尿病已是导致CKD的主要病因，而且在发展中国家，糖尿病正逐渐成为CKD的主要致病原因。美国流行病学调查显示，年龄≥20岁的T2DM患者有39.7%合并CKD。对我国住院糖尿病患者的回顾性研究表明，33.6%的糖尿病患者合并肾脏并发症。上海市区30岁以上T2DM患者CKD患病率可达63.9%。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "我国糖尿病患病率逐年升高，目前糖尿病患者约9240万，其中T2DM占90%以上。糖尿病与CKD关系密切。糖尿病患者CKD发生风险较非糖尿病者增加2.6倍。近年，各地CKD流行病学调查成年人CKD的患病率存在一定差异，为9%~14%。近期全国CKD流行病学调查显示，我国成年人中CKD患病率为10.8%，据此估算18岁以上人群CKD患者人数约1.195亿。在发达国家，糖尿病已是导致CKD的主要病因，而且在发展中国家，糖尿病正逐渐成为CKD的主要致病原因。美国流行病学调查显示，年龄≥20岁的T2DM患者有39.7%合并CKD。对我国住院糖尿病患者的回顾性研究表明，33.6%的糖尿病患者合并肾脏并发症。",
          "start_idx": 0,
          "end_idx": 301,
          "entities": [
            {
              "entity_id": "T37",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 5
            },
            {
              "entity_id": "T38",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 15,
              "end_idx": 18
            },
            {
              "entity_id": "T39",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 29,
              "end_idx": 33
            },
            {
              "entity_id": "T40",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 29,
              "end_idx": 31
            },
            {
              "entity_id": "T41",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 40,
              "end_idx": 43
            },
            {
              "entity_id": "T42",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 44,
              "end_idx": 47
            },
            {
              "entity_id": "T43",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 52,
              "end_idx": 55
            },
            {
              "entity_id": "T44",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 57,
              "end_idx": 60
            },
            {
              "entity_id": "T45",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 66,
              "end_idx": 69
            },
            {
              "entity_id": "T46",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 82,
              "end_idx": 85
            },
            {
              "entity_id": "T47",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 120,
              "end_idx": 123
            },
            {
              "entity_id": "T48",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 94,
              "end_idx": 97
            },
            {
              "entity_id": "T49",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 138,
              "end_idx": 141
            },
            {
              "entity_id": "T50",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 162,
              "end_idx": 165
            },
            {
              "entity_id": "T51",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 190,
              "end_idx": 193
            },
            {
              "entity_id": "T52",
              "entity": "糖尿病",
              "entity_type": "Reason",
              "start_idx": 183,
              "end_idx": 186
            },
            {
              "entity_id": "T53",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 259,
              "end_idx": 262
            },
            {
              "entity_id": "T54",
              "entity": "糖尿病",
              "entity_type": "Reason",
              "start_idx": 208,
              "end_idx": 211
            },
            {
              "entity_id": "T55",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 216,
              "end_idx": 219
            },
            {
              "entity_id": "T56",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 288,
              "end_idx": 291
            },
            {
              "entity_id": "T57",
              "entity": "肾脏",
              "entity_type": "Anatomy",
              "start_idx": 295,
              "end_idx": 297
            },
            {
              "entity_id": "T61",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 268,
              "end_idx": 271
            },
            {
              "entity_id": "T62",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 245,
              "end_idx": 249
            },
            {
              "entity_id": "T63",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 245,
              "end_idx": 247
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R13",
              "head_entity_id": "T40",
              "tail_entity_id": "T39"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R14",
              "head_entity_id": "T52",
              "tail_entity_id": "T51"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R15",
              "head_entity_id": "T54",
              "tail_entity_id": "T55"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R16",
              "head_entity_id": "T57",
              "tail_entity_id": "T56"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R18",
              "head_entity_id": "T63",
              "tail_entity_id": "T62"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "上海市区30岁以上T2DM患者CKD患病率可达63.9%。",
          "start_idx": 301,
          "end_idx": 330,
          "entities": [
            {
              "entity_id": "T58",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 9,
              "end_idx": 13
            },
            {
              "entity_id": "T59",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 9,
              "end_idx": 11
            },
            {
              "entity_id": "T60",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 15,
              "end_idx": 18
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R17",
              "head_entity_id": "T59",
              "tail_entity_id": "T58"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "4",
      "paragraph": "二、T2DM合并CKD的诊断与分期",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "二、T2DM合并CKD的诊断与分期",
          "start_idx": 0,
          "end_idx": 17,
          "entities": [
            {
              "entity_id": "T64",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6
            },
            {
              "entity_id": "T65",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T66",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R19",
              "head_entity_id": "T65",
              "tail_entity_id": "T64"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "5",
      "paragraph": "CKD是指肾脏结构或功能异常持续超过3个月，其诊断标准见表1。目前国内外大部分指南是根据GFR来进行CKD的肾功能分期。(表2)",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "CKD是指肾脏结构或功能异常持续超过3个月，其诊断标准见表1。目前国内外大部分指南是根据GFR来进行CKD的肾功能分期。",
          "start_idx": 0,
          "end_idx": 60,
          "entities": [
            {
              "entity_id": "T67",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 3
            },
            {
              "entity_id": "T68",
              "entity": "肾脏结构或功能异常",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 14
            },
            {
              "entity_id": "T69",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 44,
              "end_idx": 47
            },
            {
              "entity_id": "T70",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 50,
              "end_idx": 53
            },
            {
              "entity_id": "T71",
              "entity": "肾功能",
              "entity_type": "Test_items",
              "start_idx": 54,
              "end_idx": 57
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R20",
              "head_entity_id": "T69",
              "tail_entity_id": "T70"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R21",
              "head_entity_id": "T71",
              "tail_entity_id": "T70"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "(表2)",
          "start_idx": 60,
          "end_idx": 64,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "6",
      "paragraph": "GFR是评价肾脏功能的重要指标之一，我国估算肾小球滤过率(eGFR)课题协作组改良简化MDRD方程，制定了适合我国CKD患者的eGFR的评估公式：eGFR[ml/(min·1.73m2)]=175×Scr-1.234(mg/dL)×年龄-0.179(女性×0.79)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "GFR是评价肾脏功能的重要指标之一，我国估算肾小球滤过率(eGFR)课题协作组改良简化MDRD方程，制定了适合我国CKD患者的eGFR的评估公式：eGFR[ml/(min·1.73m2)]=175×Scr-1.234(mg/dL)×年龄-0.179(女性×0.79)。",
          "start_idx": 0,
          "end_idx": 134,
          "entities": [
            {
              "entity_id": "T72",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 57,
              "end_idx": 60
            },
            {
              "entity_id": "T73",
              "entity": "eGFR",
              "entity_type": "Test_items",
              "start_idx": 63,
              "end_idx": 67
            },
            {
              "entity_id": "T74",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 0,
              "end_idx": 3
            },
            {
              "entity_id": "T75",
              "entity": "肾小球滤过率(eGFR)",
              "entity_type": "Test_items",
              "start_idx": 22,
              "end_idx": 34
            },
            {
              "entity_id": "T76",
              "entity": "eGFR",
              "entity_type": "Test_items",
              "start_idx": 73,
              "end_idx": 77
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R22",
              "head_entity_id": "T74",
              "tail_entity_id": "T72"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R23",
              "head_entity_id": "T75",
              "tail_entity_id": "T72"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R24",
              "head_entity_id": "T73",
              "tail_entity_id": "T72"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R25",
              "head_entity_id": "T76",
              "tail_entity_id": "T72"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "7",
      "paragraph": "三、T2DM合并CKD的口服降糖药选择",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "三、T2DM合并CKD的口服降糖药选择",
          "start_idx": 0,
          "end_idx": 19,
          "entities": [
            {
              "entity_id": "T77",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6
            },
            {
              "entity_id": "T78",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T79",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11
            },
            {
              "entity_id": "T80",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 12,
              "end_idx": 14
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R26",
              "head_entity_id": "T78",
              "tail_entity_id": "T77"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "8",
      "paragraph": "1.选药原则：T2DM合并CKD的理想降糖治疗策略是在有效降糖的同时，不增加低血糖发生的风险，也应避免诱发乳酸性酸中毒或增加心力衰竭风险。口服降糖药的选择应基于药物的药代动力学特征以及患者的肾功能水平综合判断。在使用某些低血糖风险较大的口服降糖药时需严格监测血糖，确保随机血糖>5mmol/L以避免低血糖的发生。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.选药原则：T2DM合并CKD的理想降糖治疗策略是在有效降糖的同时，不增加低血糖发生的风险，也应避免诱发乳酸性酸中毒或增加心力衰竭风险。",
          "start_idx": 0,
          "end_idx": 69,
          "entities": [
            {
              "entity_id": "T81",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 11
            },
            {
              "entity_id": "T82",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 7,
              "end_idx": 9
            },
            {
              "entity_id": "T83",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 13,
              "end_idx": 16
            },
            {
              "entity_id": "T84",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 38,
              "end_idx": 41
            },
            {
              "entity_id": "T85",
              "entity": "乳酸性酸中毒",
              "entity_type": "ADE",
              "start_idx": 53,
              "end_idx": 59
            },
            {
              "entity_id": "T86",
              "entity": "心力衰竭",
              "entity_type": "ADE",
              "start_idx": 62,
              "end_idx": 66
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R27",
              "head_entity_id": "T82",
              "tail_entity_id": "T81"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "口服降糖药的选择应基于药物的药代动力学特征以及患者的肾功能水平综合判断。",
          "start_idx": 69,
          "end_idx": 105,
          "entities": [
            {
              "entity_id": "T87",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 0,
              "end_idx": 2
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "在使用某些低血糖风险较大的口服降糖药时需严格监测血糖，确保随机血糖>5mmol/L以避免低血糖的发生。",
          "start_idx": 105,
          "end_idx": 156,
          "entities": [
            {
              "entity_id": "T88",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 5,
              "end_idx": 8
            },
            {
              "entity_id": "T89",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 13,
              "end_idx": 15
            },
            {
              "entity_id": "T90",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 24,
              "end_idx": 26
            },
            {
              "entity_id": "T91",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 31,
              "end_idx": 33
            },
            {
              "entity_id": "T92",
              "entity": ">5mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 33,
              "end_idx": 41
            },
            {
              "entity_id": "T93",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 44,
              "end_idx": 47
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "9",
      "paragraph": "2.血糖控制目标值：对T2DM合并CKD患者的血糖控制目标应遵循个体化原则，尽量避免低血糖的发生。《中国成人2型糖尿病HbA1c控制目标的专家共识》建议对T2DM合并CKD患者的HbA1c可适当放宽控制在7%~9%，一方面避免血糖水平控制过低而出现低血糖，另一方面避免血糖水平过高而出现代谢异常及感染。当CKD导致红细胞寿命缩短时，HbA1c检测结果可能被低估。在晚期CKD患者，使用糖化血清蛋白反映血糖控制水平可能更可靠。应监测空腹及餐后血糖以更好地了解血糖控制情况。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.血糖控制目标值：对T2DM合并CKD患者的血糖控制目标应遵循个体化原则，尽量避免低血糖的发生。《中国成人2型糖尿病HbA1c控制目标的专家共识》建议对T2DM合并CKD患者的HbA1c可适当放宽控制在7%~9%，一方面避免血糖水平控制过低而出现低血糖，另一方面避免血糖水平过高而出现代谢异常及感染。当CKD导致红细胞寿命缩短时，HbA1c检测结果可能被低估。在晚期CKD患者，使用糖化血清蛋白反映血糖控制水平可能更可靠。",
          "start_idx": 0,
          "end_idx": 212,
          "entities": [
            {
              "entity_id": "T94",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T95",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T96",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 11,
              "end_idx": 13
            },
            {
              "entity_id": "T97",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 20
            },
            {
              "entity_id": "T98",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 23,
              "end_idx": 25
            },
            {
              "entity_id": "T99",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 42,
              "end_idx": 45
            },
            {
              "entity_id": "T100",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 54,
              "end_idx": 59
            },
            {
              "entity_id": "T101",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 54,
              "end_idx": 56
            },
            {
              "entity_id": "T102",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 59,
              "end_idx": 64
            },
            {
              "entity_id": "T103",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 77,
              "end_idx": 81
            },
            {
              "entity_id": "T104",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 77,
              "end_idx": 79
            },
            {
              "entity_id": "T105",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 83,
              "end_idx": 86
            },
            {
              "entity_id": "T106",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 89,
              "end_idx": 94
            },
            {
              "entity_id": "T107",
              "entity": "7%~9%",
              "entity_type": "Test_Value",
              "start_idx": 102,
              "end_idx": 107
            },
            {
              "entity_id": "T108",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 113,
              "end_idx": 115
            },
            {
              "entity_id": "T109",
              "entity": "过低",
              "entity_type": "Test_Value",
              "start_idx": 119,
              "end_idx": 121
            },
            {
              "entity_id": "T110",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 124,
              "end_idx": 127
            },
            {
              "entity_id": "T111",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 134,
              "end_idx": 136
            },
            {
              "entity_id": "T112",
              "entity": "过高",
              "entity_type": "Test_Value",
              "start_idx": 138,
              "end_idx": 140
            },
            {
              "entity_id": "T113",
              "entity": "代谢异常",
              "entity_type": "Disease",
              "start_idx": 143,
              "end_idx": 147
            },
            {
              "entity_id": "T114",
              "entity": "感染",
              "entity_type": "Disease",
              "start_idx": 148,
              "end_idx": 150
            },
            {
              "entity_id": "T115",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 152,
              "end_idx": 155
            },
            {
              "entity_id": "T116",
              "entity": "红细胞寿命缩短",
              "entity_type": "Pathogenesis",
              "start_idx": 157,
              "end_idx": 164
            },
            {
              "entity_id": "T117",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 166,
              "end_idx": 171
            },
            {
              "entity_id": "T118",
              "entity": "晚期CKD",
              "entity_type": "Disease",
              "start_idx": 182,
              "end_idx": 187
            },
            {
              "entity_id": "T119",
              "entity": "晚期",
              "entity_type": "Class",
              "start_idx": 182,
              "end_idx": 184
            },
            {
              "entity_id": "T120",
              "entity": "糖化血清蛋白",
              "entity_type": "Test_items",
              "start_idx": 192,
              "end_idx": 198
            },
            {
              "entity_id": "T121",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 200,
              "end_idx": 202
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R28",
              "head_entity_id": "T96",
              "tail_entity_id": "T95"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R29",
              "head_entity_id": "T98",
              "tail_entity_id": "T95"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R30",
              "head_entity_id": "T98",
              "tail_entity_id": "T97"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R31",
              "head_entity_id": "T101",
              "tail_entity_id": "T100"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R32",
              "head_entity_id": "T102",
              "tail_entity_id": "T100"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R33",
              "head_entity_id": "T106",
              "tail_entity_id": "T103"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R34",
              "head_entity_id": "T104",
              "tail_entity_id": "T103"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R35",
              "head_entity_id": "T108",
              "tail_entity_id": "T103"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R36",
              "head_entity_id": "T111",
              "tail_entity_id": "T103"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R37",
              "head_entity_id": "T106",
              "tail_entity_id": "T105"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R38",
              "head_entity_id": "T108",
              "tail_entity_id": "T105"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R39",
              "head_entity_id": "T111",
              "tail_entity_id": "T105"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R40",
              "head_entity_id": "T117",
              "tail_entity_id": "T115"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R41",
              "head_entity_id": "T116",
              "tail_entity_id": "T115"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R42",
              "head_entity_id": "T119",
              "tail_entity_id": "T118"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R43",
              "head_entity_id": "T120",
              "tail_entity_id": "T118"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R44",
              "head_entity_id": "T121",
              "tail_entity_id": "T118"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "应监测空腹及餐后血糖以更好地了解血糖控制情况。",
          "start_idx": 212,
          "end_idx": 235,
          "entities": [
            {
              "entity_id": "T122",
              "entity": "空腹及餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 10
            },
            {
              "entity_id": "T123",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 16,
              "end_idx": 18
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "10",
      "paragraph": "3.口服降糖药的选择：口服降糖药作为临床最常用的降糖手段，对于T2DM合并CKD患者的血糖控制具有重要意义。但口服降糖药种类繁多，各类药物的药代动力学差异显著，某些CKD患者对经肾排泄药物或其活性代谢产物的清除减少，因而伴随着不同程度的低血糖风险。因此，必须充分了解各种药物的药代动力学特点，结合患者肾功能情况进行个体化选择，确保在有效降糖的同时不增加低血糖风险。对于大多数药物，当GFR低于60ml/(min·1.73m2)时需酌情减量或停药。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.口服降糖药的选择：口服降糖药作为临床最常用的降糖手段，对于T2DM合并CKD患者的血糖控制具有重要意义。",
          "start_idx": 0,
          "end_idx": 54,
          "entities": [
            {
              "entity_id": "T124",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T125",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 11,
              "end_idx": 13
            },
            {
              "entity_id": "T126",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 31,
              "end_idx": 35
            },
            {
              "entity_id": "T127",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 31,
              "end_idx": 33
            },
            {
              "entity_id": "T128",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 37,
              "end_idx": 40
            },
            {
              "entity_id": "T129",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 43,
              "end_idx": 45
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R45",
              "head_entity_id": "T127",
              "tail_entity_id": "T126"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R46",
              "head_entity_id": "T129",
              "tail_entity_id": "T126"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R47",
              "head_entity_id": "T129",
              "tail_entity_id": "T128"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "但口服降糖药种类繁多，各类药物的药代动力学差异显著，某些CKD患者对经肾排泄药物或其活性代谢产物的清除减少，因而伴随着不同程度的低血糖风险。",
          "start_idx": 54,
          "end_idx": 124,
          "entities": [
            {
              "entity_id": "T130",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 1,
              "end_idx": 3
            },
            {
              "entity_id": "T131",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 31
            },
            {
              "entity_id": "T132",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 64,
              "end_idx": 67
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "因此，必须充分了解各种药物的药代动力学特点，结合患者肾功能情况进行个体化选择，确保在有效降糖的同时不增加低血糖风险。",
          "start_idx": 124,
          "end_idx": 182,
          "entities": [
            {
              "entity_id": "T133",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 52,
              "end_idx": 55
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": "对于大多数药物，当GFR低于60ml/(min·1.73m2)时需酌情减量或停药。",
          "start_idx": 182,
          "end_idx": 223,
          "entities": [
            {
              "entity_id": "T134",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 9,
              "end_idx": 12
            },
            {
              "entity_id": "T135",
              "entity": "低于60ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 12,
              "end_idx": 31
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "11",
      "paragraph": "常用口服降糖药的药代动力学特征及其在T2DM合并CKD人群中应用的临床证据以及适用人群见图1及表3。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "常用口服降糖药的药代动力学特征及其在T2DM合并CKD人群中应用的临床证据以及适用人群见图1及表3。",
          "start_idx": 0,
          "end_idx": 50,
          "entities": [
            {
              "entity_id": "T136",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T137",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 18,
              "end_idx": 22
            },
            {
              "entity_id": "T138",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 18,
              "end_idx": 20
            },
            {
              "entity_id": "T139",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 27
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R48",
              "head_entity_id": "T138",
              "tail_entity_id": "T137"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "12",
      "paragraph": "(1)双胍类：目前，国内外指南均一致推荐二甲双胍作为T2DM控制血糖的一线用药，其主要药理作用是通过减少肝糖输出和改善外周胰岛素抵抗而降低血糖。二甲双胍可使HbA1c降低1%~2%，并可减轻体重且不增加低血糖风险。英国前瞻性糖尿病研究(UKPDS)显示，二甲双胍可降低肥胖T2DM患者心血管事件和死亡风险。二甲双胍直接以原形经肾脏排泄，当肾功能损害时易发生二甲双胍与乳酸在体内蓄积，从而增加乳酸性酸中毒风险。二甲双胍用于CKD3a期患者时减量，当GFR<45ml/(min·1.73m2)停用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)双胍类：目前，国内外指南均一致推荐二甲双胍作为T2DM控制血糖的一线用药，其主要药理作用是通过减少肝糖输出和改善外周胰岛素抵抗而降低血糖。二甲双胍可使HbA1c降低1%~2%，并可减轻体重且不增加低血糖风险。英国前瞻性糖尿病研究(UKPDS)显示，二甲双胍可降低肥胖T2DM患者心血管事件和死亡风险。二甲双胍直接以原形经肾脏排泄，当肾功能损害时易发生二甲双胍与乳酸在体内蓄积，从而增加乳酸性酸中毒风险。二甲双胍用于CKD3a期患者时减量，当GFR<45ml/(min·1.73m2)停用。",
          "start_idx": 0,
          "end_idx": 247,
          "entities": [
            {
              "entity_id": "T140",
              "entity": "双胍类",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 6
            },
            {
              "entity_id": "T141",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 24
            },
            {
              "entity_id": "T142",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 30
            },
            {
              "entity_id": "T143",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 26,
              "end_idx": 28
            },
            {
              "entity_id": "T144",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 32,
              "end_idx": 34
            },
            {
              "entity_id": "T145",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 69,
              "end_idx": 71
            },
            {
              "entity_id": "T146",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 72,
              "end_idx": 76
            },
            {
              "entity_id": "T147",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 78,
              "end_idx": 83
            },
            {
              "entity_id": "T148",
              "entity": "降低1%~2%",
              "entity_type": "Test_Value",
              "start_idx": 83,
              "end_idx": 90
            },
            {
              "entity_id": "T149",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 101,
              "end_idx": 104
            },
            {
              "entity_id": "T150",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 112,
              "end_idx": 115
            },
            {
              "entity_id": "T151",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 127,
              "end_idx": 131
            },
            {
              "entity_id": "T152",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 134,
              "end_idx": 136
            },
            {
              "entity_id": "T153",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 136,
              "end_idx": 140
            },
            {
              "entity_id": "T154",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 136,
              "end_idx": 138
            },
            {
              "entity_id": "T155",
              "entity": "心血管事件",
              "entity_type": "Disease",
              "start_idx": 142,
              "end_idx": 147
            },
            {
              "entity_id": "T156",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 142,
              "end_idx": 145
            },
            {
              "entity_id": "T157",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 153,
              "end_idx": 157
            },
            {
              "entity_id": "T158",
              "entity": "肾功能损害",
              "entity_type": "Disease",
              "start_idx": 169,
              "end_idx": 174
            },
            {
              "entity_id": "T159",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 169,
              "end_idx": 170
            },
            {
              "entity_id": "T160",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 178,
              "end_idx": 182
            },
            {
              "entity_id": "T161",
              "entity": "乳酸性酸中毒",
              "entity_type": "ADE",
              "start_idx": 195,
              "end_idx": 201
            },
            {
              "entity_id": "T162",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 204,
              "end_idx": 208
            },
            {
              "entity_id": "T163",
              "entity": "CKD3a期",
              "entity_type": "Disease",
              "start_idx": 210,
              "end_idx": 216
            },
            {
              "entity_id": "T164",
              "entity": "3a期",
              "entity_type": "Class",
              "start_idx": 213,
              "end_idx": 216
            },
            {
              "entity_id": "T165",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 223,
              "end_idx": 226
            },
            {
              "entity_id": "T166",
              "entity": "<45ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 226,
              "end_idx": 244
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R49",
              "head_entity_id": "T141",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R50",
              "head_entity_id": "T143",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R51",
              "head_entity_id": "T144",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R52",
              "head_entity_id": "T145",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R53",
              "head_entity_id": "T149",
              "tail_entity_id": "T146"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R54",
              "head_entity_id": "T151",
              "tail_entity_id": "T152"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R55",
              "head_entity_id": "T151",
              "tail_entity_id": "T153"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R56",
              "head_entity_id": "T151",
              "tail_entity_id": "T155"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R57",
              "head_entity_id": "T154",
              "tail_entity_id": "T153"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R58",
              "head_entity_id": "T156",
              "tail_entity_id": "T155"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R59",
              "head_entity_id": "T157",
              "tail_entity_id": "T158"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R60",
              "head_entity_id": "T161",
              "tail_entity_id": "T157"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R61",
              "head_entity_id": "T159",
              "tail_entity_id": "T158"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R62",
              "head_entity_id": "T160",
              "tail_entity_id": "T158"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R63",
              "head_entity_id": "T162",
              "tail_entity_id": "T163"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R64",
              "head_entity_id": "T164",
              "tail_entity_id": "T163"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R65",
              "head_entity_id": "T165",
              "tail_entity_id": "T163"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "13",
      "paragraph": "(2)磺脲类：为胰岛素促泌剂，主要药理作用是通过刺激胰岛β细胞释放胰岛素，增加体内的胰岛素水平而降低血糖。磺脲类药物可降低HbA1c1%~2%，是目前国内外指南中推荐的控制T2DM患者高血糖的主要用药。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)磺脲类：为胰岛素促泌剂，主要药理作用是通过刺激胰岛β细胞释放胰岛素，增加体内的胰岛素水平而降低血糖。磺脲类药物可降低HbA1c1%~2%，是目前国内外指南中推荐的控制T2DM患者高血糖的主要用药。",
          "start_idx": 0,
          "end_idx": 101,
          "entities": [
            {
              "entity_id": "T167",
              "entity": "磺脲类",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 6
            },
            {
              "entity_id": "T168",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 14
            },
            {
              "entity_id": "T169",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 50,
              "end_idx": 52
            },
            {
              "entity_id": "T170",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 53,
              "end_idx": 58
            },
            {
              "entity_id": "T171",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 61,
              "end_idx": 66
            },
            {
              "entity_id": "T172",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 86,
              "end_idx": 90
            },
            {
              "entity_id": "T173",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 86,
              "end_idx": 88
            },
            {
              "entity_id": "T174",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 92,
              "end_idx": 95
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R66",
              "head_entity_id": "T170",
              "tail_entity_id": "T172"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R67",
              "head_entity_id": "T170",
              "tail_entity_id": "T174"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R68",
              "head_entity_id": "T171",
              "tail_entity_id": "T172"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R69",
              "head_entity_id": "T171",
              "tail_entity_id": "T174"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R70",
              "head_entity_id": "T173",
              "tail_entity_id": "T172"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "14",
      "paragraph": "第一代磺脲类药物(如氯磺丙脲、妥拉磺脲、甲苯磺丁脲)的药物原型及其活性代谢产物主要依赖肾脏排泄，在CKD患者应用时半衰期延长，低血糖风险明显增加，因此禁用于该类患者，目前此类药物在临床上已基本被淘汰。在第二代磺脲类药物中，格列本脲的半衰期较长，其活性代谢产物约50%经肾脏排泄，可在CKD患者体内积聚，可能引起严重的低血糖，且持续时间超过24h。格列本脲仅可用于CKD1~2期的患者；3~5期禁用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "第一代磺脲类药物(如氯磺丙脲、妥拉磺脲、甲苯磺丁脲)的药物原型及其活性代谢产物主要依赖肾脏排泄，在CKD患者应用时半衰期延长，低血糖风险明显增加，因此禁用于该类患者，目前此类药物在临床上已基本被淘汰。在第二代磺脲类药物中，格列本脲的半衰期较长，其活性代谢产物约50%经肾脏排泄，可在CKD患者体内积聚，可能引起严重的低血糖，且持续时间超过24h。格列本脲仅可用于CKD1~2期的患者；3~5期禁用。",
          "start_idx": 0,
          "end_idx": 199,
          "entities": [
            {
              "entity_id": "T175",
              "entity": "第一代磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 8
            },
            {
              "entity_id": "T176",
              "entity": "氯磺丙脲",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 14
            },
            {
              "entity_id": "T177",
              "entity": "妥拉磺脲",
              "entity_type": "Drug",
              "start_idx": 15,
              "end_idx": 19
            },
            {
              "entity_id": "T178",
              "entity": "甲苯磺丁脲",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 25
            },
            {
              "entity_id": "T179",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 49,
              "end_idx": 52
            },
            {
              "entity_id": "T180",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 63,
              "end_idx": 66
            },
            {
              "entity_id": "T181",
              "entity": "第二代磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 101,
              "end_idx": 109
            },
            {
              "entity_id": "T182",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 111,
              "end_idx": 115
            },
            {
              "entity_id": "T183",
              "entity": "严重的低血糖",
              "entity_type": "ADE",
              "start_idx": 155,
              "end_idx": 161
            },
            {
              "entity_id": "T184",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 173,
              "end_idx": 177
            },
            {
              "entity_id": "T185",
              "entity": "CKD1~2期",
              "entity_type": "Disease",
              "start_idx": 181,
              "end_idx": 188
            },
            {
              "entity_id": "T186",
              "entity": "1~2期",
              "entity_type": "Class",
              "start_idx": 184,
              "end_idx": 188
            },
            {
              "entity_id": "T187",
              "entity": "3~5期",
              "entity_type": "Class",
              "start_idx": 192,
              "end_idx": 196
            },
            {
              "entity_id": "T188",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 141,
              "end_idx": 144
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R71",
              "head_entity_id": "T175",
              "tail_entity_id": "T179"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R72",
              "head_entity_id": "T180",
              "tail_entity_id": "T175"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R73",
              "head_entity_id": "T176",
              "tail_entity_id": "T179"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R74",
              "head_entity_id": "T180",
              "tail_entity_id": "T176"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R75",
              "head_entity_id": "T177",
              "tail_entity_id": "T179"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R76",
              "head_entity_id": "T180",
              "tail_entity_id": "T177"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R77",
              "head_entity_id": "T178",
              "tail_entity_id": "T179"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R78",
              "head_entity_id": "T180",
              "tail_entity_id": "T178"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R79",
              "head_entity_id": "T181",
              "tail_entity_id": "T188"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R80",
              "head_entity_id": "T183",
              "tail_entity_id": "T181"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R81",
              "head_entity_id": "T182",
              "tail_entity_id": "T188"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R82",
              "head_entity_id": "T183",
              "tail_entity_id": "T182"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R83",
              "head_entity_id": "T184",
              "tail_entity_id": "T185"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R84",
              "head_entity_id": "T186",
              "tail_entity_id": "T185"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R85",
              "head_entity_id": "T187",
              "tail_entity_id": "T185"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "15",
      "paragraph": "格列美脲的代谢产物仍有降糖活性，其代谢产物及原型的60%经肾脏排泄。格列美脲用于CKD1~2期患者无需调整剂量；3a期减量；3b~5期禁用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "格列美脲的代谢产物仍有降糖活性，其代谢产物及原型的60%经肾脏排泄。格列美脲用于CKD1~2期患者无需调整剂量；3a期减量；3b~5期禁用。",
          "start_idx": 0,
          "end_idx": 70,
          "entities": [
            {
              "entity_id": "T189",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T190",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 34,
              "end_idx": 38
            },
            {
              "entity_id": "T191",
              "entity": "CKD1~2期",
              "entity_type": "Disease",
              "start_idx": 40,
              "end_idx": 47
            },
            {
              "entity_id": "T192",
              "entity": "1~2期",
              "entity_type": "Class",
              "start_idx": 43,
              "end_idx": 47
            },
            {
              "entity_id": "T193",
              "entity": "3a期",
              "entity_type": "Class",
              "start_idx": 56,
              "end_idx": 59
            },
            {
              "entity_id": "T194",
              "entity": "3b~5期",
              "entity_type": "Class",
              "start_idx": 62,
              "end_idx": 67
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R86",
              "head_entity_id": "T190",
              "tail_entity_id": "T191"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R87",
              "head_entity_id": "T192",
              "tail_entity_id": "T191"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R88",
              "head_entity_id": "T193",
              "tail_entity_id": "T191"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R89",
              "head_entity_id": "T194",
              "tail_entity_id": "T191"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "16",
      "paragraph": "格列吡嗪和格列齐特的代谢产物均无降糖活性，虽然主要经肾脏排泄，但低血糖风险小于格列本脲和格列美脲。格列吡嗪用于CKD1~2期患者无需调整剂量；3期减量，4~5期禁用。格列齐特用于CKD1~2期患者无需调整剂量；在3a期减量，3b期用药经验有限，需谨慎用药；4~5期禁用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "格列吡嗪和格列齐特的代谢产物均无降糖活性，虽然主要经肾脏排泄，但低血糖风险小于格列本脲和格列美脲。格列吡嗪用于CKD1~2期患者无需调整剂量；3期减量，4~5期禁用。格列齐特用于CKD1~2期患者无需调整剂量；在3a期减量，3b期用药经验有限，需谨慎用药；4~5期禁用。",
          "start_idx": 0,
          "end_idx": 135,
          "entities": [
            {
              "entity_id": "T195",
              "entity": "格列吡嗪",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T196",
              "entity": "格列齐特",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 9
            },
            {
              "entity_id": "T197",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 32,
              "end_idx": 35
            },
            {
              "entity_id": "T198",
              "entity": "格列本脲",
              "entity_type": "Drug",
              "start_idx": 39,
              "end_idx": 43
            },
            {
              "entity_id": "T199",
              "entity": "格列美脲",
              "entity_type": "Drug",
              "start_idx": 44,
              "end_idx": 48
            },
            {
              "entity_id": "T200",
              "entity": "格列吡嗪",
              "entity_type": "Drug",
              "start_idx": 49,
              "end_idx": 53
            },
            {
              "entity_id": "T201",
              "entity": "CKD1~2期",
              "entity_type": "Disease",
              "start_idx": 55,
              "end_idx": 62
            },
            {
              "entity_id": "T202",
              "entity": "1~2期",
              "entity_type": "Class",
              "start_idx": 58,
              "end_idx": 62
            },
            {
              "entity_id": "T203",
              "entity": "3期",
              "entity_type": "Class",
              "start_idx": 71,
              "end_idx": 73
            },
            {
              "entity_id": "T204",
              "entity": "4~5期",
              "entity_type": "Class",
              "start_idx": 76,
              "end_idx": 80
            },
            {
              "entity_id": "T205",
              "entity": "CKD1~2期",
              "entity_type": "Disease",
              "start_idx": 89,
              "end_idx": 96
            },
            {
              "entity_id": "T206",
              "entity": "1~2期",
              "entity_type": "Class",
              "start_idx": 92,
              "end_idx": 96
            },
            {
              "entity_id": "T207",
              "entity": "3a期",
              "entity_type": "Class",
              "start_idx": 106,
              "end_idx": 109
            },
            {
              "entity_id": "T208",
              "entity": "3b期",
              "entity_type": "Class",
              "start_idx": 112,
              "end_idx": 115
            },
            {
              "entity_id": "T209",
              "entity": "4~5期",
              "entity_type": "Class",
              "start_idx": 128,
              "end_idx": 132
            },
            {
              "entity_id": "T210",
              "entity": "格列齐特",
              "entity_type": "Drug",
              "start_idx": 83,
              "end_idx": 87
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R90",
              "head_entity_id": "T197",
              "tail_entity_id": "T195"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R91",
              "head_entity_id": "T197",
              "tail_entity_id": "T196"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R92",
              "head_entity_id": "T197",
              "tail_entity_id": "T198"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R93",
              "head_entity_id": "T197",
              "tail_entity_id": "T199"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R94",
              "head_entity_id": "T200",
              "tail_entity_id": "T201"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R95",
              "head_entity_id": "T204",
              "tail_entity_id": "T201"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R96",
              "head_entity_id": "T203",
              "tail_entity_id": "T201"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R97",
              "head_entity_id": "T202",
              "tail_entity_id": "T201"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R98",
              "head_entity_id": "T206",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R99",
              "head_entity_id": "T207",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R100",
              "head_entity_id": "T208",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R101",
              "head_entity_id": "T209",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R102",
              "head_entity_id": "T210",
              "tail_entity_id": "T205"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "17",
      "paragraph": "格列喹酮的代谢产物无降糖作用且大部分从粪便排泄，仅5%经肾脏排泄，受肾功能影响较小，但用于CKD患者的临床证据有限，格列喹酮曾用于GFR10~50ml/(min·1.73m2)患者，但试验设计不尽完善。格列喹酮可用于CKD1~3期的患者且无需调整剂量；4期用药经验有限，需谨慎用药；5期禁用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "格列喹酮的代谢产物无降糖作用且大部分从粪便排泄，仅5%经肾脏排泄，受肾功能影响较小，但用于CKD患者的临床证据有限，格列喹酮曾用于GFR10~50ml/(min·1.73m2)患者，但试验设计不尽完善。格列喹酮可用于CKD1~3期的患者且无需调整剂量；4期用药经验有限，需谨慎用药；5期禁用。",
          "start_idx": 0,
          "end_idx": 146,
          "entities": [
            {
              "entity_id": "T211",
              "entity": "格列喹酮",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T212",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 45,
              "end_idx": 48
            },
            {
              "entity_id": "T213",
              "entity": "格列喹酮",
              "entity_type": "Drug",
              "start_idx": 58,
              "end_idx": 62
            },
            {
              "entity_id": "T214",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 65,
              "end_idx": 68
            },
            {
              "entity_id": "T215",
              "entity": "10~50ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 68,
              "end_idx": 88
            },
            {
              "entity_id": "T216",
              "entity": "格列喹酮",
              "entity_type": "Drug",
              "start_idx": 101,
              "end_idx": 105
            },
            {
              "entity_id": "T217",
              "entity": "CKD1~3期",
              "entity_type": "Disease",
              "start_idx": 108,
              "end_idx": 115
            },
            {
              "entity_id": "T218",
              "entity": "1~3期",
              "entity_type": "Class",
              "start_idx": 111,
              "end_idx": 115
            },
            {
              "entity_id": "T219",
              "entity": "4期",
              "entity_type": "Class",
              "start_idx": 126,
              "end_idx": 128
            },
            {
              "entity_id": "T220",
              "entity": "5期",
              "entity_type": "Class",
              "start_idx": 141,
              "end_idx": 143
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R103",
              "head_entity_id": "T211",
              "tail_entity_id": "T212"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R104",
              "head_entity_id": "T213",
              "tail_entity_id": "T212"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R105",
              "head_entity_id": "T214",
              "tail_entity_id": "T212"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R106",
              "head_entity_id": "T216",
              "tail_entity_id": "T217"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R107",
              "head_entity_id": "T218",
              "tail_entity_id": "T217"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R108",
              "head_entity_id": "T219",
              "tail_entity_id": "T217"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R109",
              "head_entity_id": "T220",
              "tail_entity_id": "T217"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "18",
      "paragraph": "(3)格列奈类：格列奈类降糖药为非磺脲类胰岛素促泌剂，主要通过刺激早相胰岛素分泌而降低餐后血糖，具有吸收快、起效快和作用时间短的特点，可降低HbA1c0.5%~2.0%，其低血糖的风险和程度较磺脲类药物轻。格列奈类主要代表药物为那格列奈和瑞格列奈。那格列奈及其代谢产物83%经肾脏排泄，随着肾功能的降低，那格列奈的活性代谢产物水平增加，而瑞格列奈却未发现此现象。瑞格列奈及其代谢产物仅8%经肾脏排泄。瑞格列奈Ⅰ期临床试验表明，使用瑞格列奈7d后，肾功能正常患者与不同程度CKD患者相比，血药浓度没有明显差别，提示瑞格列奈在CKD患者体内无蓄积。一项入选281例伴或不伴肾功能不全T2DM患者的多中心研究提示，使用瑞格列奈替换原有降糖治疗，不同程度肾功能不全亚组患者(正常、轻、中、重、极重肾功能损害)低血糖发生率均低于2%，且瑞格列奈治疗期低血糖发生率与肾功能损害程度无关。瑞格列奈用于CKD1~5期的患者无需调整剂量；如起始用药，应0.5mg起始。那格列奈用于CKD1~3a期患者时，无需调整剂量；3b~4期减量；5期禁用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)格列奈类：格列奈类降糖药为非磺脲类胰岛素促泌剂，主要通过刺激早相胰岛素分泌而降低餐后血糖，具有吸收快、起效快和作用时间短的特点，可降低HbA1c0.5%~2.0%，其低血糖的风险和程度较磺脲类药物轻。格列奈类主要代表药物为那格列奈和瑞格列奈。那格列奈及其代谢产物83%经肾脏排泄，随着肾功能的降低，那格列奈的活性代谢产物水平增加，而瑞格列奈却未发现此现象。瑞格列奈及其代谢产物仅8%经肾脏排泄。瑞格列奈Ⅰ期临床试验表明，使用瑞格列奈7d后，肾功能正常患者与不同程度CKD患者相比，血药浓度没有明显差别，提示瑞格列奈在CKD患者体内无蓄积。一项入选281例伴或不伴肾功能不全T2DM患者的多中心研究提示，使用瑞格列奈替换原有降糖治疗，不同程度肾功能不全亚组患者(正常、轻、中、重、极重肾功能损害)低血糖发生率均低于2%，且瑞格列奈治疗期低血糖发生率与肾功能损害程度无关。瑞格列奈用于CKD1~5期的患者无需调整剂量；如起始用药，应0.5mg起始。那格列奈用于CKD1~3a期患者时，无需调整剂量；3b~4期减量；5期禁用。",
          "start_idx": 0,
          "end_idx": 463,
          "entities": [
            {
              "entity_id": "T221",
              "entity": "格列奈类",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 7
            },
            {
              "entity_id": "T222",
              "entity": "格列奈类降糖药",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 15
            },
            {
              "entity_id": "T223",
              "entity": "非磺脲类胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 26
            },
            {
              "entity_id": "T224",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 43,
              "end_idx": 47
            },
            {
              "entity_id": "T225",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 70,
              "end_idx": 75
            },
            {
              "entity_id": "T226",
              "entity": "0.5%~2.0%",
              "entity_type": "Test_Value",
              "start_idx": 75,
              "end_idx": 84
            },
            {
              "entity_id": "T227",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 86,
              "end_idx": 89
            },
            {
              "entity_id": "T228",
              "entity": "磺脲类药物",
              "entity_type": "Drug",
              "start_idx": 96,
              "end_idx": 101
            },
            {
              "entity_id": "T229",
              "entity": "格列奈类",
              "entity_type": "Drug",
              "start_idx": 103,
              "end_idx": 107
            },
            {
              "entity_id": "T230",
              "entity": "那格列奈",
              "entity_type": "Drug",
              "start_idx": 114,
              "end_idx": 118
            },
            {
              "entity_id": "T231",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 119,
              "end_idx": 123
            },
            {
              "entity_id": "T232",
              "entity": "那格列奈",
              "entity_type": "Drug",
              "start_idx": 124,
              "end_idx": 128
            },
            {
              "entity_id": "T233",
              "entity": "那格列奈",
              "entity_type": "Drug",
              "start_idx": 152,
              "end_idx": 156
            },
            {
              "entity_id": "T234",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 169,
              "end_idx": 173
            },
            {
              "entity_id": "T235",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 181,
              "end_idx": 185
            },
            {
              "entity_id": "T236",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 200,
              "end_idx": 204
            },
            {
              "entity_id": "T237",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 215,
              "end_idx": 219
            },
            {
              "entity_id": "T238",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 235,
              "end_idx": 238
            },
            {
              "entity_id": "T239",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 256,
              "end_idx": 260
            },
            {
              "entity_id": "T240",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 261,
              "end_idx": 264
            },
            {
              "entity_id": "T241",
              "entity": "肾功能不全",
              "entity_type": "Disease",
              "start_idx": 284,
              "end_idx": 289
            },
            {
              "entity_id": "T242",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 284,
              "end_idx": 285
            },
            {
              "entity_id": "T243",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 289,
              "end_idx": 293
            },
            {
              "entity_id": "T244",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 289,
              "end_idx": 291
            },
            {
              "entity_id": "T245",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 306,
              "end_idx": 310
            },
            {
              "entity_id": "T246",
              "entity": "肾功能不全",
              "entity_type": "Disease",
              "start_idx": 323,
              "end_idx": 328
            },
            {
              "entity_id": "T247",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 323,
              "end_idx": 324
            },
            {
              "entity_id": "T248",
              "entity": "正常、轻、中、重、极重肾功能损害",
              "entity_type": "Disease",
              "start_idx": 333,
              "end_idx": 349
            },
            {
              "entity_id": "T249",
              "entity": "正常、轻、中、重、极重",
              "entity_type": "Level",
              "start_idx": 333,
              "end_idx": 344
            },
            {
              "entity_id": "T250",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 344,
              "end_idx": 345
            },
            {
              "entity_id": "T251",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 350,
              "end_idx": 353
            },
            {
              "entity_id": "T252",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 363,
              "end_idx": 367
            },
            {
              "entity_id": "T253",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 370,
              "end_idx": 373
            },
            {
              "entity_id": "T254",
              "entity": "肾功能损害",
              "entity_type": "Disease",
              "start_idx": 377,
              "end_idx": 382
            },
            {
              "entity_id": "T255",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 377,
              "end_idx": 378
            },
            {
              "entity_id": "T256",
              "entity": "瑞格列奈",
              "entity_type": "Drug",
              "start_idx": 387,
              "end_idx": 391
            },
            {
              "entity_id": "T257",
              "entity": "CKD1~5期",
              "entity_type": "Disease",
              "start_idx": 393,
              "end_idx": 400
            },
            {
              "entity_id": "T258",
              "entity": "1~5期",
              "entity_type": "Class",
              "start_idx": 396,
              "end_idx": 400
            },
            {
              "entity_id": "T259",
              "entity": "0.5mg",
              "entity_type": "Amount",
              "start_idx": 417,
              "end_idx": 422
            },
            {
              "entity_id": "T260",
              "entity": "那格列奈",
              "entity_type": "Drug",
              "start_idx": 425,
              "end_idx": 429
            },
            {
              "entity_id": "T261",
              "entity": "CKD1~3a期",
              "entity_type": "Disease",
              "start_idx": 431,
              "end_idx": 439
            },
            {
              "entity_id": "T262",
              "entity": "1~3a期",
              "entity_type": "Class",
              "start_idx": 434,
              "end_idx": 439
            },
            {
              "entity_id": "T263",
              "entity": "3b~4期",
              "entity_type": "Class",
              "start_idx": 450,
              "end_idx": 455
            },
            {
              "entity_id": "T264",
              "entity": "5期",
              "entity_type": "Class",
              "start_idx": 458,
              "end_idx": 460
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R110",
              "head_entity_id": "T227",
              "tail_entity_id": "T221"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R111",
              "head_entity_id": "T227",
              "tail_entity_id": "T222"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R112",
              "head_entity_id": "T227",
              "tail_entity_id": "T223"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R113",
              "head_entity_id": "T227",
              "tail_entity_id": "T228"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R114",
              "head_entity_id": "T237",
              "tail_entity_id": "T238"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R115",
              "head_entity_id": "T239",
              "tail_entity_id": "T240"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R116",
              "head_entity_id": "T245",
              "tail_entity_id": "T241"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R117",
              "head_entity_id": "T242",
              "tail_entity_id": "T241"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R118",
              "head_entity_id": "T244",
              "tail_entity_id": "T243"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R119",
              "head_entity_id": "T245",
              "tail_entity_id": "T243"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R120",
              "head_entity_id": "T245",
              "tail_entity_id": "T248"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R121",
              "head_entity_id": "T245",
              "tail_entity_id": "T246"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R122",
              "head_entity_id": "T251",
              "tail_entity_id": "T245"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R123",
              "head_entity_id": "T247",
              "tail_entity_id": "T246"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R124",
              "head_entity_id": "T250",
              "tail_entity_id": "T248"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R125",
              "head_entity_id": "T253",
              "tail_entity_id": "T252"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R126",
              "head_entity_id": "T252",
              "tail_entity_id": "T254"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R127",
              "head_entity_id": "T255",
              "tail_entity_id": "T254"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R128",
              "head_entity_id": "T256",
              "tail_entity_id": "T257"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R129",
              "head_entity_id": "T259",
              "tail_entity_id": "T256"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R130",
              "head_entity_id": "T258",
              "tail_entity_id": "T257"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R131",
              "head_entity_id": "T260",
              "tail_entity_id": "T261"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R132",
              "head_entity_id": "T262",
              "tail_entity_id": "T261"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R133",
              "head_entity_id": "T263",
              "tail_entity_id": "T261"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R134",
              "head_entity_id": "T264",
              "tail_entity_id": "T261"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "19",
      "paragraph": "(4)噻唑烷二酮类：噻唑烷二酮类为胰岛素增敏剂，主要通过增加靶细胞对IS而降低血糖，可降低HbA1c1.0%~1.5%。主要代表药物为吡格列酮和罗格列酮，均经肝脏代谢，不增加低血糖风险。该类药物的常见不良反应是液体潴留，因而对于重度心力衰竭患者应慎用。此外，绝经后妇女服用该类药物发生骨折及骨质疏松的风险增加，因此慎用于潜在骨疾病的患者(如肾性骨营养不良)。吡格列酮用于CKD1~3a期患者时，无需调整剂量；3b~5期患者用药经验有限，需谨慎用药。罗格列酮因增加心血管风险的安全性问题引起了国内外的警惕，目前美国食品药品监督管理局(FDA)已严格限制其使用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(4)噻唑烷二酮类：噻唑烷二酮类为胰岛素增敏剂，主要通过增加靶细胞对IS而降低血糖，可降低HbA1c1.0%~1.5%。主要代表药物为吡格列酮和罗格列酮，均经肝脏代谢，不增加低血糖风险。该类药物的常见不良反应是液体潴留，因而对于重度心力衰竭患者应慎用。此外，绝经后妇女服用该类药物发生骨折及骨质疏松的风险增加，因此慎用于潜在骨疾病的患者(如肾性骨营养不良)。吡格列酮用于CKD1~3a期患者时，无需调整剂量；3b~5期患者用药经验有限，需谨慎用药。罗格列酮因增加心血管风险的安全性问题引起了国内外的警惕，目前美国食品药品监督管理局(FDA)已严格限制其使用。",
          "start_idx": 0,
          "end_idx": 279,
          "entities": [
            {
              "entity_id": "T265",
              "entity": "噻唑烷二酮类",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 9
            },
            {
              "entity_id": "T266",
              "entity": "噻唑烷二酮类",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 16
            },
            {
              "entity_id": "T267",
              "entity": "胰岛素增敏剂",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 23
            },
            {
              "entity_id": "T268",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 39,
              "end_idx": 41
            },
            {
              "entity_id": "T269",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 45,
              "end_idx": 50
            },
            {
              "entity_id": "T270",
              "entity": "1.0%~1.5%",
              "entity_type": "Test_Value",
              "start_idx": 50,
              "end_idx": 59
            },
            {
              "entity_id": "T271",
              "entity": "吡格列酮",
              "entity_type": "Drug",
              "start_idx": 67,
              "end_idx": 71
            },
            {
              "entity_id": "T272",
              "entity": "罗格列酮",
              "entity_type": "Drug",
              "start_idx": 72,
              "end_idx": 76
            },
            {
              "entity_id": "T273",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 87,
              "end_idx": 90
            },
            {
              "entity_id": "T274",
              "entity": "液体潴留",
              "entity_type": "ADE",
              "start_idx": 105,
              "end_idx": 109
            },
            {
              "entity_id": "T275",
              "entity": "重度",
              "entity_type": "Level",
              "start_idx": 114,
              "end_idx": 116
            },
            {
              "entity_id": "T276",
              "entity": "心力衰竭",
              "entity_type": "Disease",
              "start_idx": 116,
              "end_idx": 120
            },
            {
              "entity_id": "T277",
              "entity": "心",
              "entity_type": "Anatomy",
              "start_idx": 116,
              "end_idx": 117
            },
            {
              "entity_id": "T278",
              "entity": "骨折",
              "entity_type": "ADE",
              "start_idx": 142,
              "end_idx": 144
            },
            {
              "entity_id": "T279",
              "entity": "骨质疏松",
              "entity_type": "ADE",
              "start_idx": 145,
              "end_idx": 149
            },
            {
              "entity_id": "T280",
              "entity": "肾性骨营养不良",
              "entity_type": "Disease",
              "start_idx": 170,
              "end_idx": 177
            },
            {
              "entity_id": "T281",
              "entity": "骨",
              "entity_type": "Anatomy",
              "start_idx": 172,
              "end_idx": 173
            },
            {
              "entity_id": "T282",
              "entity": "吡格列酮",
              "entity_type": "Drug",
              "start_idx": 179,
              "end_idx": 183
            },
            {
              "entity_id": "T283",
              "entity": "CKD1~3a期",
              "entity_type": "Disease",
              "start_idx": 185,
              "end_idx": 193
            },
            {
              "entity_id": "T284",
              "entity": "1~3a期",
              "entity_type": "Class",
              "start_idx": 188,
              "end_idx": 193
            },
            {
              "entity_id": "T285",
              "entity": "3b~5期",
              "entity_type": "Class",
              "start_idx": 204,
              "end_idx": 209
            },
            {
              "entity_id": "T286",
              "entity": "罗格列酮",
              "entity_type": "Drug",
              "start_idx": 224,
              "end_idx": 228
            },
            {
              "entity_id": "T287",
              "entity": "增加心血管风险",
              "entity_type": "ADE",
              "start_idx": 229,
              "end_idx": 236
            }
          ],
          "relations": [
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R135",
              "head_entity_id": "T273",
              "tail_entity_id": "T271"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R136",
              "head_entity_id": "T273",
              "tail_entity_id": "T272"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R137",
              "head_entity_id": "T277",
              "tail_entity_id": "T276"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R138",
              "head_entity_id": "T281",
              "tail_entity_id": "T280"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R139",
              "head_entity_id": "T282",
              "tail_entity_id": "T283"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R140",
              "head_entity_id": "T284",
              "tail_entity_id": "T283"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R141",
              "head_entity_id": "T285",
              "tail_entity_id": "T283"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R142",
              "head_entity_id": "T287",
              "tail_entity_id": "T286"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "20",
      "paragraph": "(5)α-糖苷酶抑制剂：α-糖苷酶抑制剂通过延缓碳水化合物在小肠上段的吸收而降低餐后血糖，适用于饮食结构以碳水化合物为主且餐后血糖升高的患者，可降低HbA1c0.5%~0.8%，不增加体重且有减轻体重的趋势。主要代表药物有阿卡波糖、伏格列波糖等。阿卡波糖口服后很少部分被吸收，随着肾功能的降低，阿卡波糖及其代谢产物的血药浓度显著增加。阿卡波糖可用于CKD1~3期患者；4~5期禁用。伏格列波糖可用于CKD1~3期患者；4~5期禁用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(5)α-糖苷酶抑制剂：α-糖苷酶抑制剂通过延缓碳水化合物在小肠上段的吸收而降低餐后血糖，适用于饮食结构以碳水化合物为主且餐后血糖升高的患者，可降低HbA1c0.5%~0.8%，不增加体重且有减轻体重的趋势。主要代表药物有阿卡波糖、伏格列波糖等。阿卡波糖口服后很少部分被吸收，随着肾功能的降低，阿卡波糖及其代谢产物的血药浓度显著增加。阿卡波糖可用于CKD1~3期患者；4~5期禁用。",
          "start_idx": 0,
          "end_idx": 191,
          "entities": [
            {
              "entity_id": "T288",
              "entity": "α-糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 11
            },
            {
              "entity_id": "T289",
              "entity": "α-糖苷酶抑制剂",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 20
            },
            {
              "entity_id": "T290",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 40,
              "end_idx": 44
            },
            {
              "entity_id": "T291",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 61,
              "end_idx": 65
            },
            {
              "entity_id": "T292",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 65,
              "end_idx": 67
            },
            {
              "entity_id": "T293",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 74,
              "end_idx": 79
            },
            {
              "entity_id": "T294",
              "entity": "0.5%~0.8%",
              "entity_type": "Test_Value",
              "start_idx": 79,
              "end_idx": 88
            },
            {
              "entity_id": "T295",
              "entity": "阿卡波糖",
              "entity_type": "Drug",
              "start_idx": 111,
              "end_idx": 115
            },
            {
              "entity_id": "T296",
              "entity": "伏格列波糖",
              "entity_type": "Drug",
              "start_idx": 116,
              "end_idx": 121
            },
            {
              "entity_id": "T297",
              "entity": "阿卡波糖",
              "entity_type": "Drug",
              "start_idx": 123,
              "end_idx": 127
            },
            {
              "entity_id": "T298",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 127,
              "end_idx": 129
            },
            {
              "entity_id": "T299",
              "entity": "阿卡波糖",
              "entity_type": "Drug",
              "start_idx": 147,
              "end_idx": 151
            },
            {
              "entity_id": "T300",
              "entity": "阿卡波糖",
              "entity_type": "Drug",
              "start_idx": 167,
              "end_idx": 171
            },
            {
              "entity_id": "T301",
              "entity": "CKD1~3期",
              "entity_type": "Disease",
              "start_idx": 174,
              "end_idx": 181
            },
            {
              "entity_id": "T302",
              "entity": "1~3期",
              "entity_type": "Class",
              "start_idx": 177,
              "end_idx": 181
            },
            {
              "entity_id": "T303",
              "entity": "4~5期",
              "entity_type": "Class",
              "start_idx": 184,
              "end_idx": 188
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R143",
              "head_entity_id": "T298",
              "tail_entity_id": "T297"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R144",
              "head_entity_id": "T300",
              "tail_entity_id": "T301"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R145",
              "head_entity_id": "T302",
              "tail_entity_id": "T301"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R146",
              "head_entity_id": "T303",
              "tail_entity_id": "T301"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "伏格列波糖可用于CKD1~3期患者；4~5期禁用。",
          "start_idx": 191,
          "end_idx": 216,
          "entities": [
            {
              "entity_id": "T304",
              "entity": "伏格列波糖",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 5
            },
            {
              "entity_id": "T305",
              "entity": "CKD1~3期",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 15
            },
            {
              "entity_id": "T306",
              "entity": "1~3期",
              "entity_type": "Class",
              "start_idx": 11,
              "end_idx": 15
            },
            {
              "entity_id": "T307",
              "entity": "4~5期",
              "entity_type": "Class",
              "start_idx": 18,
              "end_idx": 22
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R147",
              "head_entity_id": "T304",
              "tail_entity_id": "T305"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R148",
              "head_entity_id": "T306",
              "tail_entity_id": "T305"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R149",
              "head_entity_id": "T307",
              "tail_entity_id": "T305"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "21",
      "paragraph": "(6)二肽基肽酶-4(DPP-4)抑制剂：DPP-4抑制剂通过抑制DPP-4而减少胰升糖素样肽-1(GLP-1)在体内的失活，从而增加体内GLP-1的水平。GLP-1以葡萄糖浓度依赖的方式增强胰岛素分泌，抑制胰升血糖素分泌，并能延缓胃排空，通过中枢性食欲抑制来减少进食量。这一类降糖药由于上市较晚，缺乏临床用药经验，因此用于合并CKD的患者时应酌情减量。DPP-4抑制剂降低HbA1c弱于其他胰岛素促泌剂。目前在国内上市的DPP-4抑制剂为西格列汀、沙格列汀、维格列汀和利格列汀。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(6)二肽基肽酶-4(DPP-4)抑制剂：DPP-4抑制剂通过抑制DPP-4而减少胰升糖素样肽-1(GLP-1)在体内的失活，从而增加体内GLP-1的水平。",
          "start_idx": 0,
          "end_idx": 78,
          "entities": [
            {
              "entity_id": "T314",
              "entity": "二肽基肽酶-4(DPP-4)抑制剂",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 20
            },
            {
              "entity_id": "T315",
              "entity": "DPP-4抑制剂",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 29
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "GLP-1以葡萄糖浓度依赖的方式增强胰岛素分泌，抑制胰升血糖素分泌，并能延缓胃排空，通过中枢性食欲抑制来减少进食量。",
          "start_idx": 78,
          "end_idx": 136,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "这一类降糖药由于上市较晚，缺乏临床用药经验，因此用于合并CKD的患者时应酌情减量。",
          "start_idx": 136,
          "end_idx": 177,
          "entities": [
            {
              "entity_id": "T316",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 31
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "3",
          "sentence": "DPP-4抑制剂降低HbA1c弱于其他胰岛素促泌剂。",
          "start_idx": 177,
          "end_idx": 203,
          "entities": [
            {
              "entity_id": "T313",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 25
            },
            {
              "entity_id": "T317",
              "entity": "DPP-4抑制剂",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 8
            },
            {
              "entity_id": "T318",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 10,
              "end_idx": 15
            },
            {
              "entity_id": "T319",
              "entity": "胰岛素促泌剂",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 25
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "4",
          "sentence": "目前在国内上市的DPP-4抑制剂为西格列汀、沙格列汀、维格列汀和利格列汀。",
          "start_idx": 203,
          "end_idx": 240,
          "entities": [
            {
              "entity_id": "T308",
              "entity": "利格列汀",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 36
            },
            {
              "entity_id": "T309",
              "entity": "维格列汀",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 31
            },
            {
              "entity_id": "T310",
              "entity": "沙格列汀",
              "entity_type": "Drug",
              "start_idx": 22,
              "end_idx": 26
            },
            {
              "entity_id": "T311",
              "entity": "西格列汀",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 21
            },
            {
              "entity_id": "T312",
              "entity": "DPP-4抑制剂",
              "entity_type": "Drug",
              "start_idx": 8,
              "end_idx": 16
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "22",
      "paragraph": "西格列汀用于GFR≥50ml/(min·1.73m2)的CKD患者时无需调整剂量；GFR在30~50ml/(min·1.73m2)时减量至50mg，qd；GFR<30ml/(min·1.73m2)时用药经验有限，减量至25mg，qd。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "西格列汀用于GFR≥50ml/(min·1.73m2)的CKD患者时无需调整剂量；GFR在30~50ml/(min·1.73m2)时减量至50mg，qd；GFR<30ml/(min·1.73m2)时用药经验有限，减量至25mg，qd。",
          "start_idx": 0,
          "end_idx": 117,
          "entities": [
            {
              "entity_id": "T320",
              "entity": "西格列汀",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T321",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 6,
              "end_idx": 9
            },
            {
              "entity_id": "T322",
              "entity": "≥50ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 9,
              "end_idx": 27
            },
            {
              "entity_id": "T323",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 31
            },
            {
              "entity_id": "T324",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 41,
              "end_idx": 44
            },
            {
              "entity_id": "T325",
              "entity": "30~50ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 45,
              "end_idx": 65
            },
            {
              "entity_id": "T326",
              "entity": "50mg",
              "entity_type": "Amount",
              "start_idx": 69,
              "end_idx": 73
            },
            {
              "entity_id": "T327",
              "entity": "qd",
              "entity_type": "Frequency",
              "start_idx": 74,
              "end_idx": 76
            },
            {
              "entity_id": "T328",
              "entity": "qd",
              "entity_type": "Frequency",
              "start_idx": 114,
              "end_idx": 116
            },
            {
              "entity_id": "T329",
              "entity": "25mg",
              "entity_type": "Amount",
              "start_idx": 109,
              "end_idx": 113
            },
            {
              "entity_id": "T330",
              "entity": "<30ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 80,
              "end_idx": 98
            },
            {
              "entity_id": "T331",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 77,
              "end_idx": 80
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R150",
              "head_entity_id": "T320",
              "tail_entity_id": "T323"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R151",
              "head_entity_id": "T327",
              "tail_entity_id": "T320"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R152",
              "head_entity_id": "T326",
              "tail_entity_id": "T320"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R153",
              "head_entity_id": "T329",
              "tail_entity_id": "T320"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R154",
              "head_entity_id": "T328",
              "tail_entity_id": "T320"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R155",
              "head_entity_id": "T321",
              "tail_entity_id": "T323"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R156",
              "head_entity_id": "T324",
              "tail_entity_id": "T323"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R157",
              "head_entity_id": "T331",
              "tail_entity_id": "T323"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "23",
      "paragraph": "沙格列汀用于GFR≥50ml/(min·1.73m2)的CKD患者时无需调整剂量，当GFR在30~49ml/(min·1.73m2)时减量；CKD4~5期患者禁用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "沙格列汀用于GFR≥50ml/(min·1.73m2)的CKD患者时无需调整剂量，当GFR在30~49ml/(min·1.73m2)时减量；CKD4~5期患者禁用。",
          "start_idx": 0,
          "end_idx": 82,
          "entities": [
            {
              "entity_id": "T332",
              "entity": "沙格列汀",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T333",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 6,
              "end_idx": 9
            },
            {
              "entity_id": "T334",
              "entity": "≥50ml/(min·1.73m2",
              "entity_type": "Test_Value",
              "start_idx": 9,
              "end_idx": 26
            },
            {
              "entity_id": "T335",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 31
            },
            {
              "entity_id": "T336",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 42,
              "end_idx": 45
            },
            {
              "entity_id": "T337",
              "entity": "30~49ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 46,
              "end_idx": 66
            },
            {
              "entity_id": "T338",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 70,
              "end_idx": 73
            },
            {
              "entity_id": "T339",
              "entity": "4~5期",
              "entity_type": "Class",
              "start_idx": 73,
              "end_idx": 77
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R158",
              "head_entity_id": "T332",
              "tail_entity_id": "T335"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R159",
              "head_entity_id": "T333",
              "tail_entity_id": "T335"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R160",
              "head_entity_id": "T336",
              "tail_entity_id": "T335"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R161",
              "head_entity_id": "T339",
              "tail_entity_id": "T338"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "24",
      "paragraph": "维格列汀用于GFR≥50ml/(min·1.73m2)的CKD患者时无需调整剂量，当GFR<50ml/(min·1.73m2)时禁用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "维格列汀用于GFR≥50ml/(min·1.73m2)的CKD患者时无需调整剂量，当GFR<50ml/(min·1.73m2)时禁用。",
          "start_idx": 0,
          "end_idx": 67,
          "entities": [
            {
              "entity_id": "T340",
              "entity": "维格列汀",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T341",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 6,
              "end_idx": 9
            },
            {
              "entity_id": "T342",
              "entity": "≥50ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 9,
              "end_idx": 27
            },
            {
              "entity_id": "T343",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 31
            },
            {
              "entity_id": "T344",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 42,
              "end_idx": 45
            },
            {
              "entity_id": "T345",
              "entity": "<50ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 45,
              "end_idx": 63
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R162",
              "head_entity_id": "T340",
              "tail_entity_id": "T343"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R163",
              "head_entity_id": "T341",
              "tail_entity_id": "T343"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R164",
              "head_entity_id": "T344",
              "tail_entity_id": "T343"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "25",
      "paragraph": "一项为期52周的随机、双盲试验评估了利格列汀的疗效及安全性。受试者为既往接受其他降糖药治疗的T2DM患者，GFR<30ml/(min·1.73m2)，分别给予利格列汀或安慰剂，结果显示与安慰剂组相比，利格列汀降低HbA1c达0.6%，但利格列汀组低血糖发生率高于安慰剂组。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "一项为期52周的随机、双盲试验评估了利格列汀的疗效及安全性。受试者为既往接受其他降糖药治疗的T2DM患者，GFR<30ml/(min·1.73m2)，分别给予利格列汀或安慰剂，结果显示与安慰剂组相比，利格列汀降低HbA1c达0.6%，但利格列汀组低血糖发生率高于安慰剂组。",
          "start_idx": 0,
          "end_idx": 136,
          "entities": [
            {
              "entity_id": "T346",
              "entity": "利格列汀",
              "entity_type": "Drug",
              "start_idx": 18,
              "end_idx": 22
            },
            {
              "entity_id": "T347",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 46,
              "end_idx": 50
            },
            {
              "entity_id": "T348",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 46,
              "end_idx": 48
            },
            {
              "entity_id": "T349",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 53,
              "end_idx": 56
            },
            {
              "entity_id": "T350",
              "entity": "<30ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 56,
              "end_idx": 74
            },
            {
              "entity_id": "T351",
              "entity": "利格列汀",
              "entity_type": "Drug",
              "start_idx": 79,
              "end_idx": 83
            },
            {
              "entity_id": "T352",
              "entity": "利格列汀",
              "entity_type": "Drug",
              "start_idx": 100,
              "end_idx": 104
            },
            {
              "entity_id": "T353",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 106,
              "end_idx": 111
            },
            {
              "entity_id": "T354",
              "entity": "达0.6%",
              "entity_type": "Test_Value",
              "start_idx": 111,
              "end_idx": 116
            },
            {
              "entity_id": "T355",
              "entity": "利格列汀",
              "entity_type": "Drug",
              "start_idx": 118,
              "end_idx": 122
            },
            {
              "entity_id": "T356",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 123,
              "end_idx": 126
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R165",
              "head_entity_id": "T348",
              "tail_entity_id": "T347"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R166",
              "head_entity_id": "T349",
              "tail_entity_id": "T347"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R167",
              "head_entity_id": "T351",
              "tail_entity_id": "T347"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R168",
              "head_entity_id": "T352",
              "tail_entity_id": "T347"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R169",
              "head_entity_id": "T353",
              "tail_entity_id": "T347"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R170",
              "head_entity_id": "T356",
              "tail_entity_id": "T355"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "26",
      "paragraph": "利格列汀用于CKD1~4期患者时无需调整剂量，5期患者用药经验有限。需谨慎用药。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "利格列汀用于CKD1~4期患者时无需调整剂量，5期患者用药经验有限。",
          "start_idx": 0,
          "end_idx": 34,
          "entities": [
            {
              "entity_id": "T357",
              "entity": "利格列汀",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T358",
              "entity": "CKD1~4期",
              "entity_type": "Disease",
              "start_idx": 6,
              "end_idx": 13
            },
            {
              "entity_id": "T359",
              "entity": "1~4期",
              "entity_type": "Class",
              "start_idx": 9,
              "end_idx": 13
            },
            {
              "entity_id": "T360",
              "entity": "5期",
              "entity_type": "Class",
              "start_idx": 23,
              "end_idx": 25
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R171",
              "head_entity_id": "T357",
              "tail_entity_id": "T358"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R172",
              "head_entity_id": "T359",
              "tail_entity_id": "T358"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R173",
              "head_entity_id": "T360",
              "tail_entity_id": "T358"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "需谨慎用药。",
          "start_idx": 34,
          "end_idx": 40,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "27",
      "paragraph": "4.特殊人群的治疗：",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4.特殊人群的治疗：",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "28",
      "paragraph": "(1)儿童和青少年T2DM合并CKD患者：在儿童和青少年T2DM合并CKD患者中，缺乏对高血糖、高血压和血脂异常治疗的相关数据。但是生活方式的改变(饮食、锻炼、减肥)对减少以上危险因素有益，因此对高血糖的起始干预应从改变生活方式开始。若生活方式干预不能控制血糖，应考虑降糖药治疗。尽管ADA推荐口服降糖药作为儿童和青少年T2DM患者的一线治疗，但其中仅二甲双胍被FDA批准用于10岁以上的儿童，其使用注意事项与成人相同。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)儿童和青少年T2DM合并CKD患者：在儿童和青少年T2DM合并CKD患者中，缺乏对高血糖、高血压和血脂异常治疗的相关数据。但是生活方式的改变(饮食、锻炼、减肥)对减少以上危险因素有益，因此对高血糖的起始干预应从改变生活方式开始。若生活方式干预不能控制血糖，应考虑降糖药治疗。尽管ADA推荐口服降糖药作为儿童和青少年T2DM患者的一线治疗，但其中仅二甲双胍被FDA批准用于10岁以上的儿童，其使用注意事项与成人相同。",
          "start_idx": 0,
          "end_idx": 210,
          "entities": [
            {
              "entity_id": "T361",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 9,
              "end_idx": 13
            },
            {
              "entity_id": "T362",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 9,
              "end_idx": 11
            },
            {
              "entity_id": "T363",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 15,
              "end_idx": 18
            },
            {
              "entity_id": "T364",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 32
            },
            {
              "entity_id": "T365",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 28,
              "end_idx": 30
            },
            {
              "entity_id": "T366",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 34,
              "end_idx": 37
            },
            {
              "entity_id": "T367",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 44,
              "end_idx": 47
            },
            {
              "entity_id": "T368",
              "entity": "高血压",
              "entity_type": "Disease",
              "start_idx": 48,
              "end_idx": 51
            },
            {
              "entity_id": "T369",
              "entity": "血脂异常",
              "entity_type": "Disease",
              "start_idx": 52,
              "end_idx": 56
            },
            {
              "entity_id": "T370",
              "entity": "生活方式的改变",
              "entity_type": "Treatment",
              "start_idx": 66,
              "end_idx": 73
            },
            {
              "entity_id": "T371",
              "entity": "饮食",
              "entity_type": "Treatment",
              "start_idx": 74,
              "end_idx": 76
            },
            {
              "entity_id": "T372",
              "entity": "锻炼",
              "entity_type": "Treatment",
              "start_idx": 77,
              "end_idx": 79
            },
            {
              "entity_id": "T373",
              "entity": "减肥",
              "entity_type": "Treatment",
              "start_idx": 80,
              "end_idx": 82
            },
            {
              "entity_id": "T374",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 98,
              "end_idx": 101
            },
            {
              "entity_id": "T375",
              "entity": "改变生活方式",
              "entity_type": "Treatment",
              "start_idx": 108,
              "end_idx": 114
            },
            {
              "entity_id": "T376",
              "entity": "生活方式干预",
              "entity_type": "Treatment",
              "start_idx": 118,
              "end_idx": 124
            },
            {
              "entity_id": "T377",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 128,
              "end_idx": 130
            },
            {
              "entity_id": "T378",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 147,
              "end_idx": 149
            },
            {
              "entity_id": "T379",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 160,
              "end_idx": 164
            },
            {
              "entity_id": "T380",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 160,
              "end_idx": 162
            },
            {
              "entity_id": "T381",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 176,
              "end_idx": 180
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R174",
              "head_entity_id": "T362",
              "tail_entity_id": "T361"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R175",
              "head_entity_id": "T365",
              "tail_entity_id": "T364"
            },
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R176",
              "head_entity_id": "T370",
              "tail_entity_id": "T374"
            },
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R177",
              "head_entity_id": "T371",
              "tail_entity_id": "T374"
            },
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R178",
              "head_entity_id": "T372",
              "tail_entity_id": "T374"
            },
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R179",
              "head_entity_id": "T373",
              "tail_entity_id": "T374"
            },
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R180",
              "head_entity_id": "T375",
              "tail_entity_id": "T374"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R181",
              "head_entity_id": "T380",
              "tail_entity_id": "T379"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R182",
              "head_entity_id": "T381",
              "tail_entity_id": "T379"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "29",
      "paragraph": "(2)老年T2DM合并CKD患者：老年T2DM合并CKD患者通常有多种合并症，尤其是心血管疾病以及认知功能障碍，因此应加强对多种危险因素的管理。对该类患者尤其应注意避免低血糖的发生，适当调整降糖目标，并视患者的具体情况而选用口服降糖药；应从小剂量开始逐渐增加剂量并注意观察患者的反应和可能的不良反应。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)老年T2DM合并CKD患者：老年T2DM合并CKD患者通常有多种合并症，尤其是心血管疾病以及认知功能障碍，因此应加强对多种危险因素的管理。",
          "start_idx": 0,
          "end_idx": 72,
          "entities": [
            {
              "entity_id": "T382",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 9
            },
            {
              "entity_id": "T383",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 5,
              "end_idx": 7
            },
            {
              "entity_id": "T384",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 14
            },
            {
              "entity_id": "T385",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 19,
              "end_idx": 23
            },
            {
              "entity_id": "T386",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 19,
              "end_idx": 21
            },
            {
              "entity_id": "T387",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 25,
              "end_idx": 28
            },
            {
              "entity_id": "T388",
              "entity": "心血管疾病",
              "entity_type": "Disease",
              "start_idx": 42,
              "end_idx": 47
            },
            {
              "entity_id": "T389",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 42,
              "end_idx": 45
            },
            {
              "entity_id": "T390",
              "entity": "认知功能障碍",
              "entity_type": "Disease",
              "start_idx": 49,
              "end_idx": 55
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R183",
              "head_entity_id": "T383",
              "tail_entity_id": "T382"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R184",
              "head_entity_id": "T386",
              "tail_entity_id": "T385"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R185",
              "head_entity_id": "T389",
              "tail_entity_id": "T388"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "对该类患者尤其应注意避免低血糖的发生，适当调整降糖目标，并视患者的具体情况而选用口服降糖药；应从小剂量开始逐渐增加剂量并注意观察患者的反应和可能的不良反应。",
          "start_idx": 72,
          "end_idx": 150,
          "entities": [
            {
              "entity_id": "T391",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 15
            },
            {
              "entity_id": "T392",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 40,
              "end_idx": 42
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "30",
      "paragraph": "四、小结",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "四、小结",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "31",
      "paragraph": "我国T2DM合并CKD患者是一个数量庞大且不容忽视的人群，患者预后较仅有T2DM或仅有CKD患者更差。在临床实践中，应重视T2DM合并CKD患者口服降糖药的正确选择和规范使用。一旦GFR<60ml/(min·1.73m2)，大多数口服降糖药的药代动力学特征将会改变，低血糖及其他不良反应风险显著增加。遵循指南可使降糖达标率显著升高，低血糖风险显著降低，且入院率和治疗费用均显著下降。因而，对于T2DM合并CKD患者的口服降糖药治疗，尤应重视指南推荐和规范应用。在临床实践中，T2DM合并CKD患者应监测血糖，依据患者的肾功能分期选择合适降糖药并调整剂量，以保证有效控制血糖的同时能够最大程度减少低血糖风险。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "我国T2DM合并CKD患者是一个数量庞大且不容忽视的人群，患者预后较仅有T2DM或仅有CKD患者更差。在临床实践中，应重视T2DM合并CKD患者口服降糖药的正确选择和规范使用。一旦GFR<60ml/(min·1.73m2)，大多数口服降糖药的药代动力学特征将会改变，低血糖及其他不良反应风险显著增加。遵循指南可使降糖达标率显著升高，低血糖风险显著降低，且入院率和治疗费用均显著下降。因而，对于T2DM合并CKD患者的口服降糖药治疗，尤应重视指南推荐和规范应用。在临床实践中，T2DM合并CKD患者应监测血糖，依据患者的肾功能分期选择合适降糖药并调整剂量，以保证有效控制血糖的同时能够最大程度减少低血糖风险。",
          "start_idx": 0,
          "end_idx": 303,
          "entities": [
            {
              "entity_id": "T393",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6
            },
            {
              "entity_id": "T394",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 2,
              "end_idx": 4
            },
            {
              "entity_id": "T395",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11
            },
            {
              "entity_id": "T396",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 36,
              "end_idx": 40
            },
            {
              "entity_id": "T397",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 36,
              "end_idx": 38
            },
            {
              "entity_id": "T398",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 43,
              "end_idx": 46
            },
            {
              "entity_id": "T399",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 67,
              "end_idx": 70
            },
            {
              "entity_id": "T400",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 61,
              "end_idx": 65
            },
            {
              "entity_id": "T401",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 61,
              "end_idx": 63
            },
            {
              "entity_id": "T402",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 72,
              "end_idx": 74
            },
            {
              "entity_id": "T403",
              "entity": "GFR",
              "entity_type": "Test_items",
              "start_idx": 90,
              "end_idx": 93
            },
            {
              "entity_id": "T404",
              "entity": "<60ml/(min·1.73m2)",
              "entity_type": "Test_Value",
              "start_idx": 93,
              "end_idx": 111
            },
            {
              "entity_id": "T405",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 115,
              "end_idx": 117
            },
            {
              "entity_id": "T406",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 133,
              "end_idx": 136
            },
            {
              "entity_id": "T407",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 166,
              "end_idx": 169
            },
            {
              "entity_id": "T408",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 196,
              "end_idx": 200
            },
            {
              "entity_id": "T409",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 196,
              "end_idx": 198
            },
            {
              "entity_id": "T410",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 202,
              "end_idx": 205
            },
            {
              "entity_id": "T411",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 208,
              "end_idx": 210
            },
            {
              "entity_id": "T412",
              "entity": "T2DM",
              "entity_type": "Disease",
              "start_idx": 237,
              "end_idx": 241
            },
            {
              "entity_id": "T413",
              "entity": "T2",
              "entity_type": "Class",
              "start_idx": 237,
              "end_idx": 239
            },
            {
              "entity_id": "T414",
              "entity": "CKD",
              "entity_type": "Disease",
              "start_idx": 243,
              "end_idx": 246
            },
            {
              "entity_id": "T415",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 251,
              "end_idx": 253
            },
            {
              "entity_id": "T416",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 284,
              "end_idx": 286
            },
            {
              "entity_id": "T417",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 297,
              "end_idx": 300
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R186",
              "head_entity_id": "T394",
              "tail_entity_id": "T393"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R187",
              "head_entity_id": "T397",
              "tail_entity_id": "T396"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R188",
              "head_entity_id": "T401",
              "tail_entity_id": "T400"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R189",
              "head_entity_id": "T409",
              "tail_entity_id": "T408"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R190",
              "head_entity_id": "T413",
              "tail_entity_id": "T412"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R191",
              "head_entity_id": "T415",
              "tail_entity_id": "T412"
            }
          ]
        }
      ]
    }
  ]
}